Amantadine treatment in Parkinson ’s disease patients as a modulatory factor of SARS-Cov-2 infection

Background:Amantadine has been used for the prevention and treatment of viral influenza A, but more recently it is used mainly in PD patients. Previous studies showed a possible impact of amantadine on COVID-19 severity in patients using this drug due to other (neurological diseases, mainly PD). Therefore the aim of this study was to evaluate the possible impact of amantadine on the SARS-Cov-2 infection in Parkinson ’s disease (PD) patients.
Source: Parkinsonism and Related Disorders - Category: Neurology Authors: Source Type: research